337 related articles for article (PubMed ID: 11919155)
41. Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function.
Zheng Y; Vig M; Lyons J; Van Parijs L; Beg AA
J Exp Med; 2003 Apr; 197(7):861-74. PubMed ID: 12668645
[TBL] [Abstract][Full Text] [Related]
42. The ChIP-seq-defined networks of Bcl-3 gene binding support its required role in skeletal muscle atrophy.
Jackman RW; Wu CL; Kandarian SC
PLoS One; 2012; 7(12):e51478. PubMed ID: 23251550
[TBL] [Abstract][Full Text] [Related]
43. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
[TBL] [Abstract][Full Text] [Related]
44. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase.
Ozes ON; Mayo LD; Gustin JA; Pfeffer SR; Pfeffer LM; Donner DB
Nature; 1999 Sep; 401(6748):82-5. PubMed ID: 10485710
[TBL] [Abstract][Full Text] [Related]
45. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
[TBL] [Abstract][Full Text] [Related]
46. NF-κB but not FoxO sites in the MuRF1 promoter are required for transcriptional activation in disuse muscle atrophy.
Wu CL; Cornwell EW; Jackman RW; Kandarian SC
Am J Physiol Cell Physiol; 2014 Apr; 306(8):C762-7. PubMed ID: 24553183
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives.
Folmer F; Blasius R; Morceau F; Tabudravu J; Dicato M; Jaspars M; Diederich M
Biochem Pharmacol; 2006 Apr; 71(8):1206-18. PubMed ID: 16464438
[TBL] [Abstract][Full Text] [Related]
48. Lymphotoxin-beta receptor mediates NEMO-independent NF-kappaB activation.
Saitoh T; Nakano H; Yamamoto N; Yamaoka S
FEBS Lett; 2002 Dec; 532(1-2):45-51. PubMed ID: 12459460
[TBL] [Abstract][Full Text] [Related]
49. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.
Beg AA; Baldwin AS
Oncogene; 1994 May; 9(5):1487-92. PubMed ID: 8152812
[TBL] [Abstract][Full Text] [Related]
50. Activation of alternative NF-κB signaling during recovery of disuse-induced loss of muscle oxidative phenotype.
Remels AH; Pansters NA; Gosker HR; Schols AM; Langen RC
Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E615-26. PubMed ID: 24425759
[TBL] [Abstract][Full Text] [Related]
51. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
52. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
Bhat-Nakshatri P; Sweeney CJ; Nakshatri H
Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379
[TBL] [Abstract][Full Text] [Related]
53. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
Karin M; Ben-Neriah Y
Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071
[TBL] [Abstract][Full Text] [Related]
54. c-Rel and p65 trans-activate the monocyte chemoattractant protein-1 gene in interleukin-1 stimulated mesangial cells.
Stylianou E; Nie M; Ueda A; Zhao L
Kidney Int; 1999 Sep; 56(3):873-82. PubMed ID: 10469356
[TBL] [Abstract][Full Text] [Related]
55. Signaling pathways weigh in on decisions to make or break skeletal muscle.
Guttridge DC
Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):443-50. PubMed ID: 15192448
[TBL] [Abstract][Full Text] [Related]
56. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
[TBL] [Abstract][Full Text] [Related]
57. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.
Remouchamps C; Dejardin E
Methods Mol Biol; 2015; 1280():103-19. PubMed ID: 25736746
[TBL] [Abstract][Full Text] [Related]
58. TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta.
Liu H; Sidiropoulos P; Song G; Pagliari LJ; Birrer MJ; Stein B; Anrather J; Pope RM
J Immunol; 2000 Apr; 164(8):4277-85. PubMed ID: 10754326
[TBL] [Abstract][Full Text] [Related]
59. Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas.
O'Neil BH; Bůzková P; Farrah H; Kashatus D; Sanoff H; Goldberg RM; Baldwin AS; Funkhouser WK
Oncology; 2007; 72(1-2):97-104. PubMed ID: 18025803
[TBL] [Abstract][Full Text] [Related]
60. A quantitative study of the cell-type specific modulation of c-Rel by hydrogen peroxide and TNF-α.
Oliveira-Marques V; Silva T; Cunha F; Covas G; Marinho HS; Antunes F; Cyrne L
Redox Biol; 2013; 1(1):347-52. PubMed ID: 24024170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
